Furthermore, recent research indicates that preferential activation of cortical 5-HT1A receptors, through the use of biased agonists such as NLX-101 or NLX-204, also exerts antidepressant effects in WKY rats, thus potentially representing an innovative treatment strategy for TRD [38]. Here, HTR1A is linked to treatment resistant depression.